Type of preexisting lipid therapy predicts LDL-C response to ezetimibe (Q33241121)

24 July 2017

title

Type of preexisting lipid therapy predicts LDL-C response to ezetimibe (English)

1 reference

24 July 2017

Charles D Meyers

1

1 reference

24 July 2017

Yong S K Moon

series ordinal

2

1 reference

24 July 2017

Hoda Ghanem

series ordinal

3

1 reference

24 July 2017

Nathan D Wong

series ordinal

4

1 reference

24 July 2017

language of work or name

English

0 references

publication date

25 April 2006

1 reference

Annals of Pharmacotherapy

24 July 2017

published in

1 reference

24 July 2017

volume

40

1 reference

24 July 2017

issue

5

1 reference

24 July 2017

page(s)

818-823

1 reference

Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions

24 July 2017

cites work

1 reference

The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)

21 January 2018

1 reference

NPC1L1 haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibe

21 January 2018

1 reference

Projected coronary heart disease risk benefit with ezetimibe

21 January 2018

1 reference

Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.

21 January 2018

1 reference

Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies

21 January 2018

1 reference

Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial

21 January 2018

1 reference

Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia

21 January 2018

1 reference

Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia

21 January 2018

1 reference

Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia

21 January 2018

1 reference

Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia

21 January 2018

1 reference

Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease

21 January 2018

1 reference

Colesevelam HCl and ezetimibe combination therapy provides effective lipid-lowering in difficult-to-treat patients with hypercholesterolemia

21 January 2018

1 reference

Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia

21 January 2018

1 reference

Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: effects on plasma lipid levels

21 January 2018

1 reference

Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemia

21 January 2018

1 reference

Ezetimibe coadministered with fenofibrate: some safety questions

21 January 2018

1 reference

Effectiveness of ezetimibe in clinical practice

21 January 2018

1 reference

Synthesis and absorption markers of cholesterol in serum and lipoproteins during a large dose of statin treatment

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1G639

1 reference

24 July 2017

1 reference